Enveric Biosciences Q2 EPS $(0.76) Up From $(11.64) YoY

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.76) per share. This is a 93.47 percent increase over losses of $(11.64) per share from the same period last year.